ACE2 Inhibitors

ACE2 inhibitors, short for Angiotensin-Converting Enzyme 2 inhibitors, are a class of chemical compounds that primarily act by modulating the renin-angiotensin-aldosterone system (RAAS). These inhibitors interact with ACE2, a vital enzyme in the body, and play a crucial role in regulating blood pressure and maintaining electrolyte balance. ACE2 itself is a membrane-bound enzyme found in various tissues, including the lungs, heart, kidneys, and gastrointestinal tract. It is part of a complex regulatory network that balances the actions of different enzymes within the RAAS to regulate blood pressure and fluid balance. The primary function of ACE2 is to counterbalance the actions of another enzyme, Angiotensin-Converting Enzyme (ACE), within the RAAS. ACE converts angiotensin I to angiotensin II, a potent vasoconstrictor that can lead to increased blood pressure. ACE2, on the other hand, degrades angiotensin II into angiotensin-(1-7), a peptide that promotes vasodilation and has anti-inflammatory and cardioprotective effects. ACE2 inhibitors work by inhibiting the activity of ACE2, which can lead to an altered balance within the RAAS, potentially affecting blood pressure regulation and electrolyte balance. This class of inhibitors has garnered significant attention for their potential implications in various physiological processes and diseases, particularly in the context of conditions related to RAAS dysregulation.